| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2024 | Aug 19, 2024 | Seres Therapeutics, Inc. | Officer | Sell | 50.0 | -1,128 | -1.43% | ✓ | $947.5 |
| May 15, 2024 | May 17, 2024 | Seres Therapeutics, Inc. | Officer | Sell | 50.0 | -1,090 | -1.42% | ✓ | $1K |
| Feb 15, 2024 | Feb 16, 2024 | Seres Therapeutics, Inc. | Officer | Sell | 37.5 | -5,010 | -6.35% | ✓ | $5.4K |
| Oct 27, 2023 | Oct 31, 2023 | Seres Therapeutics, Inc. | Officer | Sell | 37.5 | -4,066 | -5.72% | ✓ | $5.5K |
| Apr 27, 2023 | May 1, 2023 | Seres Therapeutics, Inc. | Officer | Sell | 91.3 | +12,962 | 27.74% | ✓ | $36.5K |
| Oct 27, 2022 | Oct 31, 2022 | Seres Therapeutics, Inc. | Officer | Sell | 91.3 | +14,988 | 47.21% | ✓ | $39.7K |